TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
New HIV/AIDS study findings have been published by P.J. Weidle and colleagues
December 23rd, 2008
According to recent research published in the journal AIDS Patient Care and Stds, "We studied hepatic transaminases among rural Ugandans initiating highly active antiretroviral therapy ( HAART) and assessed the impact of positive serology for hepatitis B surface antigen ( HBsAg) and coadministration of therapy for tuberculosis. From July 2003 to December 2004, persons with symptomatic HIV disease or a CD4 count less than 250 cells/mm(3) and who had alanine transferase (ALT) or aspartate transferase (AST) less than 5 times the upper limit of normal were started on HAART including nevirapine (96%) or efavirenz (4%)." "Repository sera from a subset of 596...
Source: TB & Outbreaks Week (2008-12-23)
|
